|
US6664273B2
(en)
|
2001-11-26 |
2003-12-16 |
Schering Corporation |
Piperidine based MCH antagonists for treatment of obesity and CNS disorders
|
|
AU2002352878B2
(en)
|
2001-11-27 |
2007-11-22 |
Merck Sharp & Dohme Corp. |
2-Aminoquinoline compounds
|
|
DE10238865A1
(de)
*
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US20060194871A1
(en)
*
|
2003-04-11 |
2006-08-31 |
Barvian Kevin K |
Heterocyclic mchr1 antagoists
|
|
WO2005016928A1
(ja)
*
|
2003-08-15 |
2005-02-24 |
Banyu Pharmaceutical Co., Ltd. |
イミダゾピリジン誘導体
|
|
KR100747042B1
(ko)
*
|
2003-08-19 |
2007-08-07 |
솔젠트 (주) |
신물질６-메틸-３-펜에틸-３,４-디히드로-１ｈ-큐나졸린-２-티온,이의 제조방법 및 이를 유효성분으로 포함하는 미백 효능조성물
|
|
JP2007509158A
(ja)
*
|
2003-10-23 |
2007-04-12 |
グラクソ グループ リミテッド |
肥満、糖尿病、うつ病及び不安を治療するためのｍｃｈｒ１アンタゴニストとしての３−（４−アミノフェニル）チエノピリミド−４−オン誘導体
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
BRPI0507629A
(pt)
*
|
2004-02-13 |
2007-07-03 |
Banyu Pharma Co Ltd |
composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
|
|
DE102004010893A1
(de)
*
|
2004-03-06 |
2005-09-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7605176B2
(en)
|
2004-03-06 |
2009-10-20 |
Boehringer Ingelheim International Gmbh |
β-ketoamide compounds with MCH antagonistic activity
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
DE102004017934A1
(de)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7524862B2
(en)
|
2004-04-14 |
2009-04-28 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
ATE446962T1
(de)
|
2004-12-17 |
2009-11-15 |
Lilly Co Eli |
Thiazolopyridinon-derivate als mch- rezeptorantagonisten
|
|
CA2597541A1
(en)
*
|
2005-02-14 |
2006-08-17 |
Banyu Pharmaceutical Co., Ltd. |
Crystal of 4(3h)-quinazolinone derivative
|
|
EP1876179B1
(en)
*
|
2005-04-28 |
2015-03-25 |
Takeda Pharmaceutical Company Limited |
Thienopyrimidone compounds
|
|
WO2007011286A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Astrazeneca Ab |
Therapeutic agents
|
|
CA2822094C
(en)
*
|
2005-08-31 |
2015-10-27 |
Celgene Corporation |
Isoindole-imide compounds and compositions comprising and methods of using the same
|
|
RU2418803C2
(ru)
*
|
2005-10-19 |
2011-05-20 |
Киссеи Фармасьютикал Ко., Лтд. |
Конденсированное гетероциклическое производное, содержащая его лечебная композиция и ее применение в медицине
|
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
|
US8618115B2
(en)
*
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
|
ES2412007T3
(es)
|
2005-12-21 |
2013-07-09 |
Janssen Pharmaceutica, N.V. |
Derivados de pirazinona sustituida novedosos para uso en enfermedades mediadas por MCH-1
|
|
US7553836B2
(en)
*
|
2006-02-06 |
2009-06-30 |
Bristol-Myers Squibb Company |
Melanin concentrating hormone receptor-1 antagonists
|
|
RU2008136898A
(ru)
*
|
2006-02-15 |
2010-03-20 |
Санофи-Авентис (Fr) |
Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств
|
|
AU2007214710A1
(en)
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
AU2007214708A1
(en)
*
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
CA2636617A1
(en)
|
2006-02-15 |
2007-08-23 |
Lothar Schwink |
Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
|
|
WO2007142217A1
(ja)
*
|
2006-06-07 |
2007-12-13 |
Banyu Pharmaceutical Co., Ltd. |
１－フェニルピリドン誘導体
|
|
MX2008015486A
(es)
*
|
2006-06-08 |
2009-01-12 |
Lilly Co Eli |
Nuevos receptores antagonistas de la hormona concentrador de melanina (mch).
|
|
CA2652385A1
(en)
|
2006-06-08 |
2007-12-21 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
JP2010500300A
(ja)
|
2006-08-08 |
2010-01-07 |
サノフィ−アベンティス |
アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
|
|
JP2010501553A
(ja)
*
|
2006-08-18 |
2010-01-21 |
アストラゼネカ アクチボラグ |
Ｍｃｈｒ１アンタゴニストとしてのチエノピリミジン−４−オン誘導体およびチエノピリダジン−７−オン誘導体
|
|
ES2483866T3
(es)
|
2006-12-05 |
2014-08-08 |
Janssen Pharmaceutica Nv |
Derivados de diaza-espiro-piridinona sustituidos novedosos para uso en enfermedades mediadas por MCH-1
|
|
WO2008076562A1
(en)
*
|
2006-12-14 |
2008-06-26 |
Eli Lilly And Company |
5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
|
|
WO2008086404A1
(en)
|
2007-01-10 |
2008-07-17 |
Albany Molecular Research, Inc. |
5-pyridinone substituted indazoles
|
|
US7851622B2
(en)
|
2007-04-25 |
2010-12-14 |
Bristol-Myers Squibb Company |
Non-basic melanin concentrating hormone receptor-1 antagonists
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
DE102007028925A1
(de)
|
2007-06-22 |
2008-12-24 |
Saltigo Gmbh |
Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden
|
|
CN101861311A
(zh)
|
2007-07-21 |
2010-10-13 |
阿尔巴尼分子研究公司 |
5-吡啶酮取代的吲唑
|
|
JP5632612B2
(ja)
*
|
2007-12-05 |
2014-11-26 |
あすか製薬株式会社 |
ラクタム化合物又はその塩及びｐｐａｒ活性化剤
|
|
PE20091928A1
(es)
|
2008-05-29 |
2009-12-31 |
Bristol Myers Squibb Co |
Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
WO2010003624A2
(en)
|
2008-07-09 |
2010-01-14 |
Sanofi-Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
CA2689707A1
(en)
|
2009-11-16 |
2011-05-16 |
Jean-Simon Diallo |
Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening
|
|
SG178880A1
(en)
|
2009-08-26 |
2012-04-27 |
Sanofi Sa |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012036233A1
(ja)
*
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683703B1
(de)
|
2011-03-08 |
2015-05-27 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120055A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683698B1
(de)
|
2011-03-08 |
2017-10-04 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8846666B2
(en)
|
2011-03-08 |
2014-09-30 |
Sanofi |
Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
US8809324B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
KR101236188B1
(ko)
*
|
2011-03-10 |
2013-02-22 |
한국화학연구원 |
신규한 피롤로피리디논 유도체 및 그의 ｍｃｈ 수용체-1 관련 질환에 대한 치료학적 용도
|
|
HUP1100241A3
(en)
|
2011-05-06 |
2013-12-30 |
Richter Gedeon Nyrt |
Oxetane substituted pyrimidones
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
NO3175985T3
(enExample)
|
2011-07-01 |
2018-04-28 |
|
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病二環式化合物
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
PL3004138T3
(pl)
|
2013-06-05 |
2024-07-29 |
Bausch Health Ireland Limited |
Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2015185531A1
(de)
|
2014-06-05 |
2015-12-10 |
Bayer Cropscience Aktiengesellschaft |
Bicyclische verbindungen als schädlingsbekämpfungsmittel
|
|
WO2017112777A1
(en)
|
2015-12-22 |
2017-06-29 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
DK3497089T3
(da)
*
|
2016-08-12 |
2020-08-31 |
Bayer Cropscience Ag |
Fremgangsmåde til fremstilling af 4-substituerede 2,3-dihydro-1-benzofuranderivater ved cyklisering af 2-(2-diazonium-6-substituerede-phenyl)ethanolsalte
|
|
KR102537985B1
(ko)
|
2016-09-12 |
2023-05-30 |
인테그랄 헬스 인코퍼레이티드 |
Gpr120 조정제로서 유용한 단환형 화합물
|
|
WO2018049328A1
(en)
*
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Bicyclic compounds useful as gpr120 modulators
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
KR102736865B1
(ko)
|
2017-06-21 |
2024-12-03 |
샤이 테라퓨틱스 엘엘씨 |
암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
|
|
WO2019063708A1
(en)
|
2017-09-29 |
2019-04-04 |
Bayer Aktiengesellschaft |
SUBSTITUTED 3-PHENYLQUINAZOLIN-4 (3H) -ONES AND USES THEREOF
|
|
WO2019063704A1
(en)
|
2017-09-29 |
2019-04-04 |
Bayer Aktiengesellschaft |
SUBSTITUTED 3-PHENYLQUINAZOLIN-4 (3H) -ONES AND USES THEREOF
|
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
CN110563730B
(zh)
*
|
2019-07-29 |
2022-03-25 |
江苏理工学院 |
高纯度n10-三氟乙酰蝶酸的制备方法
|
|
WO2022047145A1
(en)
|
2020-08-28 |
2022-03-03 |
Arvinas Operations, Inc. |
Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use
|
|
CN113651800B
(zh)
*
|
2021-09-07 |
2022-08-19 |
山东铂源药业股份有限公司 |
一种甲磺酸奥希替尼的制备方法
|
|
EP4584258A1
(en)
|
2022-09-07 |
2025-07-16 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|